Ocular Therapeutix, Inc.OCULNASDAQ
Loading
EV to Sales HistoryNormalizing
Percentile Rank38
3Y CAGR+108.2%
5Y CAGR-13.0%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+108.2%/yr
vs -51.3%/yr prior
5Y CAGR
-13.0%/yr
Recent acceleration
Acceleration
+159.5pp
Accelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
3 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 31.18 | +91.9% |
| 2024 | 16.25 | +289.8% |
| 2023 | 4.17 | +20.6% |
| 2022 | 3.46 | -64.8% |
| 2021 | 9.82 | -84.3% |
| 2020 | 62.52 | +43.8% |
| 2019 | 43.47 | -29.3% |
| 2018 | 61.52 | +13.0% |
| 2017 | 54.46 | -46.0% |
| 2016 | 100.91 | - |